Di Nuzzo Private Wealth, Inc. Biomarin Pharmaceutical Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $658 Million
- Q2 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 12 shares of BMRN stock, worth $665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 24
50.0%
Holding current value
$665
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
674Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$874 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$837 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$681 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...